According to Benitec Biopharma latest financial reports the total liabilities of BNTC is $4.26M, an increase of 37.88% to 2022. At the end of 2022 company had $3.09M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Benitec Biopharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $4.26M | 37.88% |
2022 | $3.09M | 125.79% |
2021 | $1.37M | 1.48% |
2020 | $1.35M | -18.29% |
2019 | $1.65M | - |